Formurex strategically designs and develops customized formulations that are robust, scalable, and manufacturable based on the unique physicochemical characteristics of the selected compounds. The formulation team develops and manufactures products and processes using Quality by Design (QbD) principles, Design of Experiments (DOE), and risk-based assessment. Formurex has the capability to develop and manufacture controlled substances (Class II to Class V), potent substances, and specialty formulations such as pediatric and geriatric.
Formulation Development
Formulation Development
Oral Extended-Release Formulations - Buccal / Sublingual Formulations
- Gastroretentive Formulations
- Transdermal Formulations
- Self-Emulsifying Formulations
- Easy to Swallow Formulations
- Vaginal Formulations
- Abuse-Deterrent Formulations
- Ophthalmic Formulations
- Topical Formulations
- Parenteral Formulations
- Drug-Device Combinations
Drug Delivery Systems
Processes and Formulations
- Direct Compression
- Dry Compression / Roller Compaction
- Wet Granulation (High shear, fluid bed granulation)
- Tablet Compression (Single/ Bilayer)
- Coating (Perforated coating, fluid bed coating)
Processes:
- Conventional oral tablets
- Extended-release tablets
- Mouth-dissolving tablets
- Orally disintegrating tablets
- Effervescence tablets
- Chewable tablets
- Bioadhesive tablets
- Mini Tablets
Tablet Formulations:
- Powder Filled Capsules
- Granules Filled Capsules
- Spheroids Filled Capsules
- Mini-Tablets Filled Capsules
- Extended-release Capsules
Capsule Formulations:
- Amorphous Solid Dispersions for Solubility Enhancement
- Dry Powders for Inhalation
- Micro particles for Extended Release
Dry Powder Formulations:
- Solutions for Oral and Parenteral
- Suspensions for Oral
- Nano Suspensions for Oral and Parenteral
- Emulsions/Micro and/or Nanoemulsions for Oral and Parenteral
- Syrups for Oral
Liquid Formulations:
- Gels
- Creams
- Ointments
Topical Dosage Formulations:
